Abingdon Health Plc (AIM:ABDX)
7.43
+0.43 (6.07%)
Mar 6, 2026, 3:53 PM GMT
Abingdon Health Revenue
In the fiscal year ending June 30, 2025, Abingdon Health had annual revenue of 8.43M GBP with 37.39% growth. Abingdon Health had revenue of 5.34M in the half year ending June 30, 2025, with 81.83% growth.
Revenue
8.43M
Revenue Growth
+37.39%
P/S Ratio
3.73
Revenue / Employee
67.98K
Employees
124
Market Cap
31.42M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| AstraZeneca | 43.64B |
| GSK plc | 32.67B |
| Haleon | 11.03B |
| Smith & Nephew | 4.58B |
| ImmuPharma | -69.96K |
| Provexis | 871.27K |
| Palatin Technologies | 6.66M |
| Arecor Therapeutics | 5.06M |
Abingdon Health News
- 1 year ago - UK Stock Market News: Abingdon Health, Wood Group, Team Internet - The Armchair Trader
- 1 year ago - AIM Market Roundup: Good Energy, Beacon Energy, Abingdon Health - The Armchair Trader
- 1 year ago - Small Cap Stocks: Hummingbird, LPA Group, Cadence Minerals - The Armchair Trader